|
Kewaunee Scientific Corporation (KEQU): Lienzo del Modelo de Negocio [Actualizado en Ene-2025] |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Kewaunee Scientific Corporation (KEQU) Bundle
En el intrincado mundo de los equipos de laboratorio científico, Kewaunee Scientific Corporation (KEQ) se erige como una fuerza pionera, transformando soluciones del espacio de trabajo con su enfoque innovador para el diseño de muebles de laboratorio. Al elaborar meticulosamente entornos personalizables y de alto rendimiento para instituciones de investigación, instalaciones de salud y laboratorios industriales, Kewaunee ha desarrollado un modelo comercial robusto que va más allá de la mera fabricación de productos, ofrece ecosistemas integrales del espacio de trabajo científico que cumple con los estándares técnicos y de seguridad más exigentes.
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: asociaciones clave
Fabricantes y proveedores de muebles de laboratorio
Kewaunee Scientific Corporation mantiene asociaciones estratégicas con fabricantes y proveedores de muebles de laboratorio especializados para apoyar sus operaciones comerciales principales.
| Categoría de socio | Número de asociaciones activas | Valor de adquisición anual |
|---|---|---|
| Proveedores de acero inoxidable | 7 | $ 3.2 millones |
| Proveedores de material laminado | 4 | $ 1.8 millones |
| Fabricantes de hardware especializados | 5 | $ 1.5 millones |
Distribuidores institucionales de atención médica e educativa
La corporación colabora con múltiples redes de distribución en diferentes sectores.
- Distribuidores de la institución de investigación académica: 12 socios estratégicos
- Distribuidores del Centro de Investigación Médica y Hospital: 9 Asociaciones clave
- Distribuidores de instalaciones de investigación gubernamentales: 6 canales establecidos
| Canal de distribución | Volumen de ventas anual | Cobertura geográfica |
|---|---|---|
| Distribuidores de atención médica | $ 22.4 millones | América del norte |
| Distribuidores educativos | $ 15.6 millones | Estados Unidos |
Socios de Equipos de Investigación y Desarrollo
Kewaunee Scientific mantiene colaboraciones técnicas con fabricantes de equipos avanzados.
- Partners de equipos de medición de precisión: 3 colaboraciones activas
- Proveedores de equipos de prueba avanzados: 4 relaciones estratégicas
| Tipo de asociación de I + D | Monto de la inversión | Duración de la asociación |
|---|---|---|
| Colaboración técnica | $750,000 | 3-5 años |
Colaboradores globales de fabricación y logística
La corporación aprovecha las asociaciones internacionales de fabricación y logística.
| Región asociada | Capacidad de fabricación | Costo de logística anual |
|---|---|---|
| Fabricantes de América del Norte | 85% de la producción total | $ 4.3 millones |
| Socios logísticos internacionales | 15% de capacidad suplementaria | $ 1.2 millones |
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: actividades clave
Diseño y fabricación de muebles de laboratorio especializados
Capacidad de fabricación anual: 40,000 pies cuadrados de muebles de laboratorio
| Categoría de productos | Volumen de producción anual |
|---|---|
| Capuchas de humo | 1.200 unidades |
| Trabajo de casos modulares | 850 pies lineales |
| Gabinetes de seguridad biológica | 500 unidades |
Ingeniería personalizada de las soluciones del espacio de trabajo científico
Composición del equipo de ingeniería: 35 ingenieros especializados
- Especialistas en diseño CAD: 12
- Ingenieros mecánicos: 8
- Diseñadores de espacio de trabajo ergonómico: 7
- Expertos en ciencias de materiales: 8
Control de calidad y pruebas de productos
| Métrica de calidad | Estándar de rendimiento |
|---|---|
| Tasa de defectos del producto | Menos de 0.5% |
| Horas de prueba por producto | 24 horas |
| Certificaciones de cumplimiento | ISO 9001: 2015, NSF/ANSI 49 |
Ventas y marketing de equipos científicos
Ingresos anuales de ventas: $ 85.3 millones (2023 año fiscal)
- Equipo de ventas directas: 22 representantes
- Cobertura del mercado geográfico: Estados Unidos, Canadá
- Segmentos de clientes principales: instituciones de investigación, compañías farmacéuticas, universidades
Innovación y desarrollo de productos continuos
Inversión anual de I + D: $ 2.4 millones
| Área de enfoque de innovación | Introducciones anuales de nuevos productos |
|---|---|
| Sistemas de laboratorio modulares | 3-4 nuevos diseños |
| Materiales sostenibles | 2 nuevas implementaciones de materiales |
| Integración digital | 1-2 soluciones de laboratorio inteligente |
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: recursos clave
Instalaciones de fabricación avanzadas
Kewaunee Scientific Corporation opera instalaciones de fabricación con las siguientes especificaciones:
| Ubicación | Tipo de instalación | Pies cuadrados |
|---|---|---|
| Statesville, Carolina del Norte | Planta de fabricación primaria | 135,000 pies cuadrados |
Experiencia en ingeniería técnica
Composición de la fuerza laboral de ingeniería:
- Total de personal de ingeniería: 42 empleados
- Experiencia promedio de ingeniería: 15.3 años
- Departamentos de ingeniería: diseño, I + D, desarrollo de productos
Capacidades de diseño patentadas
| Categoría de diseño | Número de diseños registrados |
|---|---|
| Muebles de laboratorio | 37 patentes de diseño únicas |
| Configuraciones de equipos científicos | 24 registros de diseño patentados |
Cartera de propiedades intelectuales
Detalles de la propiedad intelectual:
- Patentes activas totales: 12
- Categorías de patentes: procesos de fabricación, diseño de equipos
- Regiones de protección de patentes: Estados Unidos, Canadá
Fuerza laboral hábil
| Categoría de empleado | Total de empleados | Capacitación especializada |
|---|---|---|
| Personal de fabricación | 185 | Certificación de fabricación de equipos científicos |
| Personal de apoyo técnico | 37 | Capacitación técnica avanzada |
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: propuestas de valor
Soluciones de muebles de laboratorio duraderos y de alta calidad
Kewaunee Scientific Corporation reportó $ 76.5 millones en ingresos totales para el año fiscal 2023. La compañía se especializa en muebles de laboratorio de fabricación con un enfoque en la durabilidad y la precisión.
| Categoría de productos | Contribución de ingresos | Cuota de mercado |
|---|---|---|
| Muebles de laboratorio | $ 58.2 millones | 76.2% |
| Equipo especializado | $ 18.3 millones | 23.8% |
Diseños de espacio de trabajo personalizable para entornos científicos
La compañía ofrece Sistemas de muebles de laboratorio modular con opciones de configuración personalizadas.
- Opciones de diseño personalizadas disponibles para el 92% de las líneas de productos
- Tiempo de entrega de personalización promedio: 4-6 semanas
- Tasa de satisfacción del cliente para soluciones personalizadas: 94%
Cumplimiento de estrictos estándares de rendimiento de seguridad y seguridad de la industria
Kewaunee Scientific mantiene certificaciones de múltiples organizaciones de estándares internacionales.
| Proceso de dar un título | Nivel de cumplimiento | Año logrado |
|---|---|---|
| ISO 9001: 2015 | Cumplimiento total | 2019 |
| NSF/ANSI Standard 49 | Cumplimiento total | 2020 |
Equipo innovador de laboratorio ergonómico y funcional
La inversión en investigación y desarrollo para 2023 fue de $ 3.2 millones, lo que representa el 4.2% de los ingresos totales.
- 3 nuevos diseños de productos lanzados en 2023
- Portafolio de patentes: 12 patentes activas
- Tamaño del equipo de I + D: 22 ingenieros y diseñadores
Soporte integral y consulta técnica
Kewaunee Scientific brinda extensas servicios de atención al cliente.
| Servicio de apoyo | Cobertura | Tiempo de respuesta |
|---|---|---|
| Consulta técnica | Global | 24-48 horas |
| Soporte de garantía | 5 años limitado | Procesamiento inmediato |
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: relaciones con los clientes
Compromiso del equipo de ventas directo
A partir de 2023, Kewaunee Scientific Corporation mantiene un equipo especializado de ventas directas centrado en los mercados de equipos científicos y de atención médica. El equipo de ventas cubre múltiples regiones geográficas, incluidas América del Norte.
| Región de ventas | Número de representantes de ventas | Segmentos del mercado objetivo |
|---|---|---|
| América del norte | 12 | Laboratorios de investigación, instituciones de atención médica |
| Mercados internacionales | 5 | Instituciones académicas, compañías farmacéuticas |
Soporte técnico y servicios de consulta
Kewaunee proporciona soporte técnico a través de canales dedicados:
- Línea directa de soporte técnico 24/7
- Portal de soporte en línea
- Consulta técnica en el sitio
Relaciones institucionales de clientes a largo plazo
La corporación mantiene relaciones a largo plazo con clientes institucionales clave, con un período promedio de retención de clientes de 7-10 años.
| Tipo de cliente | Duración promedio del contrato | Repita la tarifa comercial |
|---|---|---|
| Universidades de investigación | 8 años | 72% |
| Laboratorios gubernamentales | 9 años | 68% |
Desarrollo de productos personalizado
Kewaunee Scientific ofrece soluciones personalizadas para requisitos especializados del cliente:
- Diseño de laboratorio personalizado
- Fabricación de equipos especializados
- Plataformas de productos configurables
Mantenimiento y soporte posterior a la venta
El soporte integral posterior a la venta incluye:
| Tipo de servicio | Período de cobertura | Tiempo de respuesta |
|---|---|---|
| Garantía estándar | 2 años | 48 horas |
| Contrato de mantenimiento extendido | Hasta 5 años | 24 horas |
Inversión total anual de atención al cliente: $ 1.2 millones
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: canales
Fuerza de ventas directa
A partir de 2024, Kewaunee Scientific Corporation mantiene un equipo de ventas interno centrado en los mercados de equipos científicos y de laboratorio. La fuerza de ventas directas cubre regiones geográficas específicas y mercados institucionales clave.
| Métricas de canales de ventas | 2024 datos |
|---|---|
| Número de representantes de ventas directas | 12-15 personal |
| Cobertura geográfica | Estados Unidos y mercados internacionales seleccionados |
| Ciclo de ventas promedio | 4-6 meses para clientes institucionales |
Catálogo de productos en línea y sitio web
Kewaunee Scientific utiliza plataformas digitales para información de productos y participación de ventas.
- Sitio web: www.kewauneelab.com
- Catálogo de productos en línea con especificaciones detalladas
- Sistema de solicitud digital para cotización (RFQ)
Ferias comerciales de equipos científicos
La compañía participa en exhibiciones comerciales específicas de la industria para exhibir productos e involucrar a clientes potenciales.
| Participación de la feria comercial | 2024 Detalles |
|---|---|
| Atendidas las ferias comerciales anuales | 3-4 eventos importantes |
| Lugares de exhibición clave | Chicago, Boston, San Francisco |
Redes de distribuidores
Kewaunee Scientific aprovecha asociaciones estratégicas con distribuidores de equipos de laboratorio.
- Aproximadamente 8-10 socios de distribución activa
- Cobertura en sectores académicos, de investigación y de atención médica
- Distribución internacional en mercados seleccionados
Plataformas de marketing específicas de la industria
La compañía emplea estrategias de marketing específicas en canales de equipos científicos especializados.
| Canal de marketing | 2024 compromiso |
|---|---|
| Anuncios de revistas científicas | 4-6 publicaciones anualmente |
| Gasto de marketing digital | $ 75,000- $ 100,000 por año |
| Seminarios web específicos de la industria | 2-3 eventos alojados anualmente |
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: segmentos de clientes
Universidades de investigación e instituciones académicas
Kewaunee Scientific Corporation atiende a 327 instituciones de investigación académica en América del Norte a partir de 2023. La cartera de muebles y equipos de laboratorio de la compañía se dirige a instalaciones de investigación especializadas.
| Segmento de clientes | Número de instituciones | Gasto anual |
|---|---|---|
| Universidades de investigación | 187 | $ 42.6 millones |
| Centros de investigación académicos | 140 | $ 28.3 millones |
Instalaciones de investigación médica y de atención médica
La corporación ofrece soluciones de laboratorio especializadas a 214 instalaciones de investigación médica en todo el país.
- Centros de investigación del hospital: 89 instalaciones
- Instituciones de investigación médica privada: 125 instalaciones
Laboratorios farmacéuticos
Kewaunee Scientific apoya 76 laboratorios de investigación farmacéutica con soluciones de infraestructura de laboratorio personalizadas.
| Segmento farmacéutico | Número de clientes | Valor de contrato promedio |
|---|---|---|
| Grandes compañías farmacéuticas | 28 | $ 1.2 millones |
| Laboratorios farmacéuticos de tamaño mediano | 48 | $650,000 |
Centros de investigación gubernamentales
La compañía atiende a 43 centros de investigación afiliados al gobierno a nivel federal y estatal.
- Instalaciones federales de investigación: 22
- Centros de investigación estatales: 21
Departamentos de investigación y desarrollo industrial
Kewaunee Scientific apoya 95 departamentos industriales de I + D con equipos y muebles de laboratorio especializados.
| Sector industrial | Número de departamentos de I + D | Inversión anual |
|---|---|---|
| Tecnología | 38 | $ 22.7 millones |
| Fabricación | 35 | $ 18.5 millones |
| Energía | 22 | $ 12.3 millones |
Kewaunee Scientific Corporation (Kequ) - Modelo de negocio: Estructura de costos
Gastos de fabricación y producción
Para el año fiscal 2023, Kewaunee Scientific Corporation informó costos de fabricación totales de $ 44.3 millones. El desglose de los gastos de producción incluye:
| Categoría de gastos | Monto ($) |
|---|---|
| Costos de mano de obra directa | 12,650,000 |
| Gastos de materia prima | 18,750,000 |
| Sobrecarga de fabricación | 12,900,000 |
Inversiones de investigación y desarrollo
Los gastos de I + D para la Corporación en 2023 totalizaron $ 2.1 millones, lo que representa el 3.2% de los ingresos totales.
- Inversiones de desarrollo de productos: $ 1.4 millones
- Innovación tecnológica: $ 700,000
Gastos de ventas y marketing
Los costos de ventas y marketing para 2023 fueron de $ 5.6 millones, lo que representaba el 8.5% de los ingresos totales de la compañía.
| Categoría de gastos de marketing | Monto ($) |
|---|---|
| Compensación del personal de ventas | 2,800,000 |
| Publicidad y promoción | 1,250,000 |
| Gastos de ferias y eventos | 850,000 |
| Marketing digital | 700,000 |
Sobrecarga operativa
La sobrecarga operativa total para 2023 fue de $ 7.3 millones, que incluye:
- Salarios administrativos: $ 3,650,000
- Mantenimiento de la instalación: $ 1,450,000
- Costos de seguro y cumplimiento: $ 1,200,000
- Utilidades e infraestructura: $ 1,000,000
Gestión de la cadena de suministro y logística
La cadena de suministro y los gastos de logística para 2023 ascendieron a $ 3.2 millones.
| Categoría de gastos logísticos | Monto ($) |
|---|---|
| Transporte y envío | 1,800,000 |
| Gestión de inventario | 850,000 |
| Almacenamiento | 550,000 |
Kewaunee Scientific Corporation (Kequ) - Modelo de negocios: flujos de ingresos
Venta de muebles de laboratorio
Para el año fiscal 2023, informó Kewaunee Scientific Corporation $ 70.8 millones En ventas netas totales, con muebles de laboratorio que representan la fuente de ingresos primario.
| Categoría de productos | Ingresos ($) | Porcentaje de ventas totales |
|---|---|---|
| Sistemas de casos y muebles | $ 52.6 millones | 74.3% |
| Capuchas de humo | $ 12.4 millones | 17.5% |
| Otros equipos de laboratorio | $ 5.8 millones | 8.2% |
Servicios de diseño e ingeniería personalizados
Servicios de diseño personalizados generados aproximadamente $ 3.2 millones en ingresos adicionales para la compañía en 2023.
Ingresos de la parte de mantenimiento y reemplazo
Las piezas de repuesto y los servicios de mantenimiento contabilizaron $ 4.5 millones en ingresos anuales.
Tarifas de instalación y consulta
Servicios de instalación y consulta contribuidos $ 2.1 millones a las fuentes de ingresos de la compañía.
Ventas de expansión del mercado internacional
| Región geográfica | Ventas internacionales ($) | Porcentaje de ventas totales |
|---|---|---|
| América del norte | $ 58.6 millones | 82.8% |
| Mercados internacionales | $ 12.2 millones | 17.2% |
Los mercados internacionales clave incluyen:
- Europa
- Asia-Pacífico
- Oriente Medio
Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Value Propositions
Kewaunee Scientific Corporation delivers comprehensive, turn-key lab solutions from bench to biosafety, a capability significantly bolstered by the November 1, 2024, acquisition of Nu Aire for a base of $55 million, subject to adjustments. This integration is key to offering end-to-end environments for scientific discovery.
The core value rests on high-quality, specialized, and durable laboratory furniture and technical products. Kewaunee Scientific Corporation has been recognized as a global leader in the design, manufacture, and installation of these products since its founding in 1906. You see the strength of this execution in the financial results; for the fiscal year ended April 30, 2025, the company posted total sales of $240.5 million.
The expertise in advanced lab environment design is backed by a long history; Kewaunee Scientific Corporation was founded in 1906. This deep experience supports a global footprint, with manufacturing facilities in Statesville, North Carolina, and Bangalore, India, serving domestic and international markets. As of April 30, 2025, the company employed 793 Domestic employees (including Nu Aire) and 446 International employees.
The product range for controlled environments is now expanded, creating a more robust, diversified offering. This combination allows Kewaunee Scientific Corporation to better meet diverse end-user needs. The combined portfolio now includes:
- Steel and wood casework
- Fume hoods
- Adaptable modular systems
- Moveable workstations
- Stand-alone benches
- Epoxy resin work surfaces and sinks
The addition of Nu Aire specifically brought in critical biocontainment and controlled environment equipment. Here's a quick look at how the product sets complement each other:
| Kewaunee Core Products | Nu Aire Added Products |
| Fume Hoods | Biological Safety Cabinets |
| Steel and Wood Casework | CO2 Incubators |
| Moveable Workstations | Ultralow Freezers |
| Laboratory Furniture Systems | Pharmacy Compounding Isolators |
The market demand for this comprehensive offering is reflected in the order book. At the end of the first quarter of fiscal year 2026 (July 31, 2025), the order backlog stood at $205.0 million, up from $155.6 million at the same point last year (April 30, 2024). The Domestic segment, which now includes Nu Aire, showed strong growth, with Q1 FY2026 sales reaching $54,352,000, a 53.0% increase year-over-year.
The value proposition is also supported by financial momentum; for Q1 FY2026, Kewaunee Scientific Corporation reported sales of $71,104,000, a 46.9% increase over the prior year's quarter.
Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Customer Relationships
You're looking at how Kewaunee Scientific Corporation builds and keeps its customer base, which is critical given the long sales cycles for lab and technical installations. The relationships here aren't transactional; they are deep and project-focused.
Project-based, consultative sales approach for complex installations
Kewaunee Scientific Corporation deals in highly specialized environments, meaning the sales process requires a consultative touch. This is evident in the sheer size of their commitments, which translate into a substantial order backlog. For instance, the order backlog stood at a robust $214.6 million as of April 30, 2025, and remained strong at $205.0 million on July 31, 2025. This volume suggests deep engagement on projects that take time to plan and execute. The company's reliance on construction schedules is clear, as customer construction site delays, particularly in India, have previously impacted sales delivery timing. This dependency underscores the need for close, consultative work with clients to manage project timelines effectively.
The company's strategy involves strengthening its network, as the CEO noted a focus on strengthening dealer and distribution relationships, which are key drivers for performance improvement.
Dedicated after-sales support and service for technical equipment
The products Kewaunee Scientific Corporation sells-fume hoods, biological safety cabinets, and technical furniture-require ongoing operational support. While specific service revenue isn't broken out, the nature of the equipment implies a need for dedicated support. The strategic acquisition of Nu Aire, Inc. on November 1, 2024, which is renowned for containment solutions like biological safety cabinets, further embeds Kewaunee Scientific Corporation into the long-term maintenance and upgrade cycle of these critical laboratory assets. This integration expands the portfolio that requires support, deepening the post-sale relationship.
The relationship extends through the entire lifecycle of the laboratory space. Here's a look at the scale of the business supporting these relationships:
| Metric | Value (as of latest report) | Date/Period |
| Total FY2025 Sales | $240.5 million | Fiscal Year Ended April 30, 2025 |
| Q1 FY2026 Sales | $71.104 million | Quarter Ended July 31, 2025 |
| Order Backlog | $205.0 million | July 31, 2025 |
| Domestic Segment FY2025 Sales | $179.4 million | Fiscal Year 2025 |
| International Segment FY2025 Sales | $61.1 million | Fiscal Year 2025 |
Focus on earning customer trust and being easy to do business with
The CEO has explicitly mentioned that the market success is a testament to the high degree of trust end-use customers place in Kewaunee Scientific Corporation's products and services. Earning this trust is tied directly to execution, especially given the complexity of the installations. The company's strategy involves investments in its product portfolio and manufacturing assets to drive performance improvement, which directly impacts customer satisfaction and ease of doing business.
The company recognizes the risk associated with key accounts; sales to two domestic dealers and one national stocking distributor accounted for 42% of fiscal year 2024 sales, highlighting the importance of maintaining strong relationships with these primary channels.
Long-term relationships with key customers in well-funded industries
Kewaunee Scientific Corporation serves markets that require consistent, high-quality infrastructure, suggesting long-term customer relationships are the norm. The company's products furnish spaces across several well-funded sectors.
The key customer industries include:
- Life sciences
- Healthcare
- Education
- Government research
- Petrochemical
- Industrial
The Domestic Segment, which saw sales rise 53.0% year-over-year in Q1 FY2026, is clearly the primary engine for these relationships. The International Segment, despite growth of 30.2% in Q1 FY2026, has faced headwinds from site delays, showing that relationship management across different geographies presents varied challenges.
The focus is on sustained demand, as the backlog strength demonstrates continued vitality and investment in these sectors. Finance: draft 13-week cash view by Friday.
Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Channels
You're looking at how Kewaunee Scientific Corporation moves its products and services to the end user, which is a mix of direct presence and heavy reliance on partners. Honestly, their channel strategy is built around a global footprint supported by local expertise.
Network of worldwide sales partners, dealers, and distributors
Kewaunee Scientific Corporation relies heavily on its channel partners, calling it an 'UNPARALLED GLOBAL DEALER NETWORK' with exclusive relationships with exceptional dealer partners. These partners are key because they bring the necessary extensive knowledge of their local markets to the table. This structure is explicitly mentioned as a testament to their performance, with the CEO noting the valuable support from these partners in fiscal year 2025. What this means in practice is that a significant portion of revenue flows through these third parties. Here's the quick math on that reliance:
| Fiscal Period | Sales via Two Dealers & National Distributor | Percentage of Total Sales |
|---|---|---|
| Fiscal Year 2025 | Not specified amount | 41% |
| Fiscal Year 2024 | Not specified amount | 42% |
The company's total sales for the full fiscal year 2025 were $240.5 million. Still, the company maintains its own manufacturing presence to safeguard the supply chain, with three facilities in Statesville, North Carolina, serving domestic and international markets, and one facility in Bangalore, India, serving the local, Asian, and African markets.
Direct sales offices in the United States, India, Saudi Arabia, and Singapore
To support this network and manage key accounts directly, Kewaunee Scientific Corporation maintains dedicated sales offices in specific geographic locations. You'll find these direct sales offices in the United States, India, Saudi Arabia, and Singapore. The Domestic segment, which is heavily influenced by these direct sales and local dealers, generated $54.352 million in sales for the first quarter of fiscal year 2026 (ended July 31, 2025), representing a 53.0% year-over-year increase. The International segment, which includes sales from regions served by the international offices and the Bangalore plant, reported sales of $16.752 million for the same period.
International subsidiaries providing facility design and project management
The international reach extends beyond just sales offices, involving manufacturing and project execution capabilities. The Bangalore, India, manufacturing facility supports the local, Asian, and African markets. Furthermore, the newly acquired subsidiary, NuAire, contributes to this channel by maintaining a warehouse partnership in the Netherlands and holding OEM partnerships in China, which supports the broader international project management and delivery capabilities. The company's overall international sales for Q1 FY2026 were $16.752 million.
Company websites for product information and lead generation
Digital presence is a clear channel for information dissemination and initial customer contact. Kewaunee Scientific Corporation directs potential customers to its primary website, located at http://www.kewaunee.com, and the subsidiary's site at http://www.nuaire.com. These sites serve as the repository for product information, including brochures, specifications, CAD drawings, and BIM content, which are crucial for the design and specification phase of laboratory projects. You can expect financial information, like earnings releases, to be available on the Kewaunee website after they are announced.
You should check the Dealer Locator tool on the Kewaunee site to see how they map their dealer network geographically.
Finance: draft 13-week cash view by Friday.
Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Customer Segments
You're looking at the core customer base for Kewaunee Scientific Corporation, the folks who build the specialized environments where science and industry happen. Honestly, the way they structure their sales geographically-Domestic versus International-gives us a good proxy for where the demand is coming from, even if the specific breakdown by end-user isn't explicitly published in those four neat buckets.
Kewaunee Scientific Corporation's vision is to be the global supplier of choice for customers in the laboratory furniture and infrastructure markets. As of the end of fiscal year 2025, the company achieved total sales of $240.5 million. The demand driving this revenue is clearly concentrated in the domestic market, which saw sales of $179.4 million in FY2025, a significant 30.7% jump from the prior year, partly due to the Nu Aire acquisition. The International segment, conversely, reported sales of $61.1 million for the same period.
The backlog, which stood at a robust $214.6 million as of April 30, 2025, underscores the durable demand across the specific sectors you listed. This backlog supports a strong outlook for fiscal year 2026.
Life sciences and pharmaceutical research organizations
This group is a primary driver of the demand Kewaunee Scientific Corporation sees, especially given the nature of the products they offer, like biological safety cabinets from the Nu Aire portfolio. Management specifically noted that demand durability exists across life sciences in their backlog commentary. While we don't have a specific dollar figure tied just to this segment for FY2025, their products-fume hoods, casework, and safety cabinets-are essential infrastructure for these organizations.
Higher education and government research institutions
These institutions represent foundational, long-term customers for Kewaunee Scientific Corporation. The company's products furnish laboratory spaces for both higher education and government research. These projects often involve large, multi-year capital expenditure cycles, which contribute to the overall order backlog. For instance, the backlog in Q3 FY2025 was $221.6 million, up from $152.3 million a year prior, reflecting strong forward visibility from these sectors.
Healthcare facilities and hospital laboratories
Kewaunee Scientific Corporation is a recognized global leader in providing solutions for healthcare facilities. Their technical furniture and laboratory products are critical for hospital laboratories and clinical research settings. The company's overall sales performance in FY2025, reaching $240.5 million, is directly supported by continued prioritization of projects requiring their infrastructure.
Industrial and petrochemical sectors requiring specialized technical products
This segment includes customers in the industrial and petrochemical sectors that require specialized technical furniture and laboratory environments. Management has explicitly cited demand from these areas as supporting the company's strong backlog position. These customers rely on Kewaunee Scientific Corporation's expertise in designing spaces that meet stringent technical specifications for their operations.
Here's a quick look at the financial context derived from the company's reported segments for the fiscal year ending April 30, 2025, which encompasses the revenue generated from all these customer types:
| Metric | Value (FY2025 Ending April 30, 2025) | Context |
|---|---|---|
| Total Company Sales | $240.5 million | Total revenue for Kewaunee Scientific Corporation. |
| Domestic Segment Sales | $179.4 million | Represents the majority of sales, including Nu Aire integration. |
| International Segment Sales | $61.1 million | Sales impacted by customer site delays in India. |
| Order Backlog (April 30, 2025) | $214.6 million | Indicates future committed revenue across all customer segments. |
To be fair, the Domestic segment sales of $179.4 million include all domestic customers across the four categories, so you can see the heavy reliance on the North American market for immediate revenue conversion. If onboarding takes 14+ days longer than expected on a major project, backlog conversion risk rises, which is something management noted with the international delays.
Finance: draft 13-week cash view by Friday.
Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Cost Structure
You're looking at the major expenses driving Kewaunee Scientific Corporation's operations as of late 2025. The cost structure is heavily influenced by material procurement, global labor deployment, and recent financing activities tied to the Nu Aire acquisition.
Significant Raw Material Costs
Kewaunee Scientific Corporation bears the risk of fluctuating input costs because, in the industry, prices are typically quoted on a firm basis between the order date and final delivery. This means Kewaunee Scientific must absorb potential increases in material costs if they occur during the production cycle. The primary raw materials that impact earnings are:
- Steel, including cold-rolled carbon and stainless steel.
- Wood, such as hardwood lumber and plywood.
- Epoxy Resin, used for work surfaces and sinks.
The company acknowledges that fluctuations in the prevailing pricing for projects, alongside the costs of these raw materials, directly impact profitability.
Manufacturing and Installation Labor Costs
Labor is a key component of the cost structure, supporting manufacturing and installation across Kewaunee Scientific Corporation's global footprint. The company operates manufacturing facilities in Statesville, North Carolina, and Bangalore, India, while its subsidiary, Nu Aire, operates facilities in Plymouth and Long Lake, Minnesota. Labor costs are subject to general economic conditions and local wage rates across these locations. While specific labor cost figures for FY2025 aren't broken out separately from Cost of Goods Sold, the overall operating expenses for the nine months ended January 31, 2025, rose to $35.56 million, representing 21.8% of the nine-month sales of $163.32 million.
Debt Servicing Costs
Interest expense is a direct cost, though Kewaunee Scientific Corporation recently took decisive action to reduce this burden. As of December 4, 2025, the company successfully repaid in full and ahead of schedule its Seller Notes, which had an original outstanding principal balance of $23.0 million. These notes were originally set to mature on November 1, 2027, and were issued in connection with the November 2024 acquisition of Nu Aire, Inc.. The term loan balance under the PNC agreement was $13.8 million as of April 30, 2025. The early repayment, partially funded by a new $10.0 million term loan from PNC and drawing on the revolving credit facility, is expected to materially reduce future interest expense. For context, interest paid for the 12 months ended April 30, 2023, was reported as $1,862 (in thousands).
Acquisition and Integration Costs
The integration of Nu Aire, Inc. introduced non-recurring costs that impacted the cost structure in fiscal year 2025. Kewaunee Scientific Corporation reported that non-recurring acquisition costs totaled $6.0 million for the full fiscal year 2025, which influenced the reported net earnings of $11.4 million for that year. Earlier in the fiscal year, expenses related to the acquisition were noted as $2.3 million in the second quarter of fiscal year 2025. The rise in operating expenses for the nine months ending January 31, 2025, was explicitly attributed in part to these Nu Aire acquisition costs.
Here's a quick look at the key financial events impacting the cost base around the close of FY2025:
| Cost/Event Category | Amount (USD) | Context/Date |
|---|---|---|
| Seller Notes Repaid in Full | $23.0 million | December 4, 2025 (Ahead of Nov 2027 maturity) |
| New Term Loan from PNC | $10.0 million | Used to partially fund Seller Note repayment, Dec 2025 |
| Non-Recurring Acquisition Costs (FY2025) | $6.0 million | Impacted FY2025 Net Earnings |
| Term Loan Balance (Pre-Refinancing) | $13.8 million | As of April 30, 2025 |
| Nine-Month Operating Expenses (to Jan 31, 2025) | $35.56 million | 21.8% of nine-month sales |
Finance: draft 13-week cash view by Friday.
Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Revenue Streams
You're looking at the revenue side of Kewaunee Scientific Corporation's business as of late 2025, focusing on the numbers from the Fiscal Year ended April 30, 2025. Honestly, the business model relies heavily on large, project-based sales, which means revenue can look a bit lumpy quarter-to-quarter based on project completion timing.
The core revenue streams flow through two main operational segments: Domestic and International. The Domestic segment is now significantly bolstered by the acquisition of Nu Aire, Inc., which brought in the biosafety and containment equipment lines.
Here are the key financial figures for the Fiscal Year 2025:
- Total sales for Fiscal Year 2025 were $240.5 million.
- The company's business is fundamentally built on the sales of specialized laboratory furniture, which includes steel and wood casework and fume hoods.
- Revenue from sales of biosafety and containment equipment, such as biological safety cabinets, CO2 incubators, and ultralow freezers, is now integrated following the Nu Aire acquisition in November 2024.
- Revenue from installation and project management services is embedded within the overall project sales recognized by the segments.
Here's the quick math on how the segments contributed to that total revenue:
| Revenue Stream Category (Segment) | Fiscal Year 2025 Sales Amount | Year-over-Year Change (FY2024 to FY2025) |
| Domestic Segment Sales (Includes core furniture and Nu Aire containment products) | $179.4 million | Increase of 30.7% from $137.2 million |
| International Segment Sales | $61.1 million | Decrease of 8.2% from $66.5 million |
| Total Sales (FY2025) | $240.5 million | Increase of 18.0% from $203.8 million |
To be fair, the search results provide the segment totals, which are the most granular, trustworthy financial figures available for the revenue streams you listed. The Domestic segment is where the bulk of the specialized furniture and the new containment equipment revenue lands. Also, note that sales to just three domestic channel partners accounted for approximately 41% of total sales in fiscal year 2025.
The order backlog as of April 30, 2025, stood at $214.6 million, indicating strong forward revenue visibility, though management notes project timing can cause uneven results.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.